This document stipulates the technical requirements for ApoE genotyping testing and puts forward recommendations for personalized non-drug treatment of Alzheimer's disease (AD). The main provisions include: ApoE genotyping: clarifying the association between the ApoE gene and Alzheimer's disease and the distribution of ApoE gene polymorphisms. ApoE genotyping testing requirements: Specific requirements are clarified in terms of sample collection and processing, ApoE genotyping testing methods, etc. Several suggestions for non-drug treatment of Alzheimer's disease: Suggestions for non-drug treatment of AD are proposed from the aspects of lifestyle intervention, cognitive intervention and multi-modal intervention, exercise training, and other therapies.
T/SRMA 19-2023 history
2023T/SRMA 19-2023 General requirements for ApoE typing tests for Alzheimer's disease susceptibility genes